Latest News

TILT preparations during the corona pandemic

TILT preparations during the corona pandemic

The ongoing pandemic affects TILT less than some other companies. This is because we don’t have regular sales. Instead, our operations are based on long term research and development. It is clear corona might cause unexpected delays in the upcoming year, but likely these can be compensated for afterwards. The management team of the company is relatively small and few are members of any risk group. Most of our work can be performed from home offices. Laboratory work is currently allowed to continue in Finland. Production of our drug has been completed. Most of our costs are outsourced, giving us flexibility should the global situation worsen. We will stay vigilant and modify our plans as needed.

Latest News

Upcoming Events

Please contact our business development team to meet us at the following events:

28-29th February 2024
Sachs Annual European Life Sciences CEO Forum
Zurich, Switzerland
18-20th March 2024
BIO-Europe
Barcelona, Spain
12-14th May 2024
Bio€quity Europe
San Sebastián, Spain
5-10th April 2024
AACR Annual Meeting
San Diego (CA), USA
31st May - 4th June 2024
ASCO Annual Meeting
Chicago (IL), USA
3-6th June 2024
BIO International Convention
San Diego (CA), USA